-
srdrplus.ahrq.gov/published_projects?page=45
June 23, 2021 - No adverse events were reported. … Pharmacological therapies were associated with increased risk of adverse events versus placebo (SOE:
-
srdrplus.ahrq.gov/published_projects?page=20
June 27, 2021 - There was no statistically significant difference in death, total adverse events or serious adverse events
-
srdrplus.ahrq.gov/published_projects?page=23
June 27, 2021 - with pooled SVR rates that ranged from 95.5 percent to 98.9 percent across genotypes; rates of serious adverse … events (1.9%) and withdrawal due to adverse events (0.4%) were low.
-
srdrplus.ahrq.gov/published_projects?page=18
October 06, 2021 - We did not find systematic differences across interventions in serious adverse events radiation necrosis
-
srdrplus.ahrq.gov/published_projects?page=21
June 27, 2021 - Evidence on harms of pharmacotherapies was limited, but indicated no increased risk of serious adverse … events.
-
srdrplus.ahrq.gov/published_projects?page=49
June 23, 2021 - to no difference in HbA1c reduction, but some combinations increased risk for hypoglycemia and other adverse … events. … effects derived relative risks (RR) for most analyses and Peto’s Odds Ratios (OR) in comparisons of rare events
-
srdrplus.ahrq.gov/published_projects?page=30
June 27, 2021 - Further, lithium improved acute mania better than topiramate, although withdrawals for adverse events
-
srdrplus.ahrq.gov/published_projects?page=8
May 30, 2023 - Most studies evaluated changes in weight/body composition, adverse events, length of hospital stay and